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Abstract
The complex phenotypic and genetic nature of anxieties hampers progress in unravelling their molecular etiologies.
Dogs present extensive natural variation in fear and anxiety behaviour and could advance the understanding of the
molecular background of behaviour due to their unique breeding history and genetic architecture. As dogs live as part
of human families under constant care and monitoring, information from their behaviour and experiences are easily
available. Here we have studied the genetic background of fearfulness in the Great Dane breed. Dogs were scored and
categorised into cases and controls based on the results of the validated owner-completed behavioural survey. A
genome-wide association study in a cohort of 124 dogs with and without socialisation as a covariate revealed a
genome-wide significant locus on chromosome 11. Whole exome sequencing and whole genome sequencing
revealed extensive regions of opposite homozygosity in the same locus on chromosome 11 between the cases and
controls with interesting neuronal candidate genes such as MAPK9/JNK2, a known hippocampal regulator of anxiety.
Further characterisation of the identified locus will pave the way for molecular understanding of fear in dogs and may
provide a natural animal model for human anxieties.
Introduction
Fear is an emotional state that is caused by any stimulus
that is interpreted to predict or cause danger. Fear pro-
duces a behavioural reaction that aims for the survival of
the animal1,2. However, increased and overscale fearful-
ness and anxiety are considered psychiatric conditions in
humans and behavioural problems in dogs. In humans,
anxiety disorders and specific phobias have estimated
lifetime prevalences of over 15%1 and 7.4%, respectively3.
While these disorders are heritable, they are genetically
complex, emphasising the need of physiologically relevant
animal models to facilitate the discovery of molecular
etiologies4–8.
Domestic dogs have emerged as important large animal
models of disease, morphology, and behaviour due to
their naturally occurring phenotypes, unique genetic
architecture and physiological similarity, and shared living
environment with humans9. Various anxieties are com-
monly reported in dogs, and can dramatically impair their
welfare. For example, dogs showing fear towards strangers
have significantly shorter lifespans when compared to
non-fearful dogs10. Dogs’ fearful reactions vary from
withdrawing, staying close to the owner, or having a tail in
a low position or placed between legs to behaviours such
as barking, growling, or even biting, thus creating a ser-
ious health concern also for humans11. In dogs, fear can
be categorised into social and non-social fearfulness. The
social category includes fear of unfamiliar people and dogs
while the non-social category includes fear of novel
situations12. Our previous study suggested that fear of
strange people is correlated both with fear of strange dogs
and with fear of novel situations13. Nearly 60% of dogs
showing fear of strangers were fearful in novel situations
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and the two traits were considered together as aspects of
general fearfulness in our previous genome-wide asso-
ciation study (GWAS)13,14.
The challenge of reliably measuring behaviour and its
heritable component together with the complex genetic
structure underlying behaviour15 have slowed down the
process of discovering loci or genetic variants for canine
behaviour. We recently reported novel loci for canine
fearfulness and noise sensitivity14. In addition, we have
previously reported changes such as increased plasma
glutamine levels in fearful dogs16,17. Candidate loci and
genes have also been reported for example for canine fear
and aggression18, social behaviour19,20, and obsessive-
compulsive disorder21,22.
In addition to the genetic risk factors, environment has
a prominent effect on fearful behaviour23,24. Pet dogs live
their whole lives in human families and are closely
monitored by their owners, enabling valid assessment of
potentially important environmental factors. One factor
that has a known, important role on a dog’s behaviour is
the level of socialisation that the dog experiences during
its puppyhood23,25,26. A limited amount of experiences
from the surrounding world during this period is known
to increase fearful behaviour in dogs13,26. Identification
and incorporation of the environmental contributors such
as socialisation into genetic analyses is important and may
offer additional consolidation for a genetic signal24.
In this study, we have addressed the genetic background
of fear of strangers in the Great Dane (GD) breed. We
collected altogether 124 GD dogs with a phenotypic score
using our validated behavioural survey. A GWAS and
whole exome and genome sequencing revealed a novel
locus on chromosome 11 that harbours interesting
candidate genes.
Materials and methods
Study cohorts and phenotypic categorisation
A previously published and validated owner-completed
behavioural survey focusing on fearfulness was used to
recruit Finnish Great Dane dogs to the study13,27. The
breed was chosen due to a large number of owner- and
breeder-reported dogs that were fearful when meeting
unfamiliar people.
Altogether 124 GD dogs were phenotyped (Fig. 1) using
our validated behavioural questionnaire27. The dogs were
categorised to cases and controls based on a categorical
quantitative “stranger fear score” (SFS)13. The SFS
describes the frequency and intensity of a fearful reaction
towards unfamiliar people. The dogs with an SFS value of
0 showed no fearful reactions when meeting unfamiliar
people and are referred to as controls. Additionally, it was
required that in the questionnaire, the owners of the dogs
included in the control cohort had chosen one of the
following options when describing their dogs’ behaviour
when meeting a novel person: “greets strangers sponta-
neously (if given a chance)”, “jumps, licks, is eager” or
“sniffs, wags tail and is calm”. Any dog with an SFS value
above 0 showed at least a mild fearful reaction and is thus
referred to as a case. The SFS was calculated as follows:
(sum of fearful behavioural reactions when meeting
unfamiliar people, where withdrawal was multiplied by
5) × (frequency of fear reactions when meeting unfamiliar
people) (Supplementary Table 1). The range of possible
SFS values was from 0 to 48 with intervals of 1, with the
dogs that showed the most severe and frequent fear
reactions gaining the highest stranger fear (SF) scores.
Avoidance was emphasised in the scoring by a factor of 5
because it is a clear, common fear reaction that is easily
recognised by owners14,28. The case or control status of a
sub-cohort (15 cases and 13 controls) of the SF-cohort
was validated by a behavioural test27. Canine personality
has been shown to be stable from 1 year onwards29, while
it has also been suggested that fearfulness as a personality
trait could be reliably observed in dogs already at the age
Fig. 1 Distribution of the stranger fear and socialisation scores.
The stranger fear score (a) was available for a total of 124 dogs. The
socialisation score (b) was available for 110 dogs included in the
stranger fear cohort. Both scores were distributed from 0 to 30 and
the dogs with a stranger fear score of 0 were used as controls in the
analyses.
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of 6 months30. Thus, all control dogs were required to be
over 1 year old while in the case-cohort, dogs slightly
under 1 year old could be included if the dog had been
through the behavioural test to confirm its status.
Based on the questionnaire answers, a socialisation
score (SS) describing the extent and frequency of
socialisation events during a dog’s puppyhood was also
calculated. The score was used as a covariate in the
genetic analyses, as socialisation is known to have a
large effect on fearfulness in dogs23,25. The SS was cal-
culated as a sum of socialisation event frequencies
during a developmental period when the dog was
between 7 weeks and 3 months of age (Supplementary
Table 2). SS was previously shown to have excellent
repeatability when evaluating the test–retest repeat-
ability of the behavioural questionnaire23. The range of
possible SS values was from 0 to 35 with intervals of 1,
with the dogs that had been exposed to the highest
amount of socialisation gaining the highest SSs. The SS
was not available for 14 dogs with an SFS. For analysis
purposes, the SS was divided into four ordered sub-
categories as follows: category 1: scores from 0 to 10;
category 2: scores from 10 to 20; category 3: scores from
21 to 24; and category 4: scores from 25 to 35.
According to our previous study, 57.1% of dogs that
showed fearfulness when meeting a stranger were also
fearful in novel situations13 and the two traits were
studied together as general fearfulness in Sarviaho
et al.14. In this study, we only focused on the fear of
strangers. The score describing the fear in novel situa-
tions was not available for all 124 dogs included in this
study (for details about the score, see Sarviaho et al.14).
Out of the 72 controls in this study, a score that
describes the level of fear they show in novel situations
was available for 35 dogs. Among the 52 cases, 27 dogs
had an available fear of novel situations score (Supple-
mentary Table 3). Out of the 35 controls, three dogs
showed fear in novel situations while out of the 27 cases,
the equivalent number was 18. The fear in novel situa-
tions score was not used as an inclusion criterion in this
study.
Samples
Ethylenediamine tetraacetic acid blood samples were
collected from 124 privately owned GD dogs for DNA.
The blood samples were stored at −20 °C and genomic
DNA was extracted by using a semi-automated Chema-
gen extraction robot (PerkinElmer Chemagen Technolo-
gie). A Qubit 3.0 Fluorometer (Thermo Fisher Scientific)
and a NanoDrop ND-1000 UV/Vis Spectrophotometer
were used to determine DNA concentration. Sample
collection was ethically approved by the Animal Ethics
Committee of State Provincial Office of Southern Finland,
Hämeenlinna, Finland (ESAVI/6054/04.10.03/2012).
Genome-wide association study
Altogether 124 GDs were genotyped using Illumina’s
Canine HD (173k) single nucleotide polymorphism (SNP)
arrays (Fig. 1). The data was analysed by treating SF as a
quantitative trait based on the categorical SF score
(Fig. 1). The initial analysis cohort included 52 cases (29
females and 23 males) and 72 controls (44 females and 28
males), where cases had an SFS between 1 and 30 and all
controls had a value of 0. In the analysis cohort in which
the SS was included as an environmental covariate for SFS
(“socialisation cohort”), the number of cases was 44 (23
females and 21 males) and of controls 66 (40 females and
26 males). The genotype data was filtered with a SNP call
rate of >90%, individual call rate of >90%, minor allele
frequency of >1%, and by using a Hardy–Weinberg
equilibrium test of P ≥ 1 × 10−8. After the quality control,
no individual dogs were removed and 122,529 SNPs
remained for analysis. Genotyping data was analysed
using a quantitative trait association analysis and linear
regression association analysis in PLINK31, and a FASTA
generalised linear mixed model approach implemented in
the R package GenABEL32. The analyses were performed
using a quantitative trait approach (Fig. 1). Multi-
dimensional scaling and quantile–quantile plots were
drawn to evaluate the existence of potential confounding
signals due to cryptic relatedness and population stratifi-
cation in the study populations (Supplementary Fig. 1).
In order to adjust the data for relatedness and popula-
tion stratification, we used genomic control approach
with PLINK33 and a genomic control approach or a
polygenic effect term with marker-estimated relationship
matrix in GenABEL34. To account for multiple testing,
Bonferroni correction was implemented to adjust the
genome-wide significance threshold. As the Bonferroni
method assumes independence between tests and is thus
overly conservative for GWAS, the effective number of
independent tests was estimated with simpleM35 and the
threshold of significance calculated as described by Mik-
kola et al.36. The estimated effective number of indepen-
dent tests was 34,271 for the whole cohort and 32,773 for
the covariate cohort in the PLINK analyses. In the Gen-
ABEL analyses, the numbers were 34,097 and 32,678,
respectively. The significance level after adjusting with
Bonferroni correction was 4.08 × 10−7 (Fig. 2a–d). We
also adjusted the significance level with the estimated
number of independent tests, which resulted in a
threshold of 1.46 × 10−6 for the PLINK analysis (Fig. 2a)
and 1.47 × 10−6 for GenABEL (Fig. 2b) in the whole
cohort analyses. For the covariate cohort, the significance
level was 1.53 × 10−6 for both analyses (Fig. 2c, d). The
linkage structure within the associated regions was
determined by using PLINK’s clump command. A win-
dow size of 4000 kb was used while other settings were
used as default.
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Exome and whole genome sequencing
Dog exome libraries for eight GD cases and eight GD
controls were generated from standard indexed Illumina
libraries using a custom Roche/Nimblegen solution-based
capture library (120705_CF3_Uppsala_Broad_EZ_HX1) as
previously described by Elvers et al.37. The 16 dogs were
chosen from among the GWAS cohort based on the best
SNP from GWAS (chr11:430548G>A; BICF2P368048)
being from opposite haplotypes, except for one case that
was a heterozygote. The dogs represented medium to severe
Fig. 2 GWAS for stranger fear. a A Manhattan plot of a quantitative trait analysis (PLINK) illustrates best p-values on chromosome 11 in a genome-
wide analysis with no included covariate. b A Manhattan plot of a mixed model association analysis (GenABEL) illustrates best p-values on
chromosome 11 in a genome-wide analysis with no included covariate. c A Manhattan plot (PLINK) based on a linear regression association analysis
illustrates best p-values on chromosome 11 in a genome-wide analysis with socialisation score as a covariate. d A Manhattan plot of a mixed model
association analysis (GenABEL) illustrates best p-values on chromosome 11 in a genome-wide analysis with socialisation score as a covariate. The red
intact line refers to a threshold of significance based on Bonferroni corrected values, while the red dashed line indicates a threshold of significance
calculated with simpleM. e A genotype plot of a region on chromosome 11 from 0 to 4 Mb indicates a difference in the allelic distributions between
cases and controls around the best SNP of the region at 430,548 Mb. f A genotype plot of a region on chromosome 11 from 12.4 to 13.1 Mb indicates
a difference in the allelic distributions in the region between cases and controls around the best SNPs of the region at 12,792,149 and 12,810,167 Mb.
Light grey and dark blue colours indicate the opposite homotsygote genotypes while the light blue colour indicates a heterotsygote genotype g The
associated genomic region includes several candidate genes.
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SF phenotypes, with SF scores between 16 and 28. In
addition, four cases and four controls were tested with a
behavioural test as described in ref. 27. The exome
sequencing was performed in Science for Life Laboratory
(Sweden). Out of the 16 exome sequenced dogs, four GD
cases and two GD controls were whole genome sequenced
using the Illumina HiSeqX platform at Novogene (Novogen
(HK) Company Limited, China) and the data was further
processed as previously described by Hytönen and Lohi38.
For filtering the sequencing data, Genotype Query
Tools39,40 and our in-house analysis pipeline were used41.
For the exome sequences, the sequencing coverage was on
average 26–104× per sample and on average 105,843 var-
iants per sample were revealed. For the whole genome
sequences, the numbers were 26–33× and 6,574,191,
respectively. While filtering the exome sequences, cases
were filtered against the controls under a dominant model
(which assumes that a variant shared by the cases is present
either as heterozygous or homozygous), allowing a max-
imum of two cases to be wildtype homozygotes for each
variant. Additionally, the controls were filtered against the
cases, allowing two controls to be wildtype homozygotes for
each variant. While filtering the whole genome sequences,
the four cases were filtered against the two controls under a
dominant model, allowing each variant to be missing from a
maximum of one case. To predict the functional effects of
the variants, Ensembl’s Variant Effect Predictor was used42.
Allele frequencies were calculated for the variants by uti-
lising 1084 exome and whole genome sequences available
through our database and collaborators in the Dog Bio-
medical Variant Database Consortium. Conservation scores
(CS) were generated with Clustal Omega43. Mobile element
insertions (MEI) and structural variants (SV), including
insertions, deletions, duplications, and intra-chromosomal
re-arrangements were identified as described in Dillard
et al.44 and by filtering the whole genome sequencing
(WGS) cases against the controls under a dominant model.
Throughout the study, the CanFam 3.1 genome build
was used as a reference. The short read data in BAM
format for 16 WES and six WGS Great Dane samples is
submitted to NCBI SRA with the BioProject ID:
PRJNA630029.
Sanger sequencing
Samples from altogether 40 GD dogs, including 15 cases
(with SF scores ranging from 3 to 25) and 25 controls were
used in PCR and Sanger sequencing in order to study three
candidate variants (chr11:1472008G>A (SNP1292825),
chr11:3390145GGGGAA>G (rs851847854) and chr11:
3416964G>T (rs851521203)) identified in WES and WGS.
To amplify the variant region, forward and reverse primers
were designed (see Supplementary Table 4) and used
together with AmpliTaq Gold 360 Mastermix (Applied
Biosystems, Life Technologies) or Biotools’ DNA
Polymerase. After treatment with exonuclease I and shrimp
alkaline phosphatase, the sequencing reactions were per-
formed using an ABI 3730 capillary sequencer (Applied
Biosystems, Life Technologies) at the Institute for Mole-
cular Medicine Finland (FIMM). The sequence data were
analysed using Sequencher 5.1 (GeneCodes).
Results
Altogether 124 GD were phenotyped for fearfulness
towards strange people. To evaluate the intensity of the
fearful reactions, a quantitative categorical “stranger
fear” score (SFS) was established. Examples of a fearful
and a non-fearful dog in a behavioural testing situation
can be seen in Supplementary Video 1. Additionally, a
quantitative categorical score evaluating the amount of
socialisation (SS) during the dogs’ puppyhood was
calculated and used as a covariate in the analyses. Due
to the SS not being available for all 124 dogs, the
covariate cohort included 110 dogs. The SFS values of
cases varied between 1 and 30 while all control dogs
had a value of 0. In both cohorts, the median value of
SFS in cases was 16 and an average SFS value was 14.6
(Fig. 1a). The SS values varied between 3 and 30 with a
median value of 21.5 and an average of 20.2 (Fig. 1b).
The distribution of the SS, an environmental factor
affecting SF, was rather similar between cases and
controls, suggesting a genetic component for SF (Fig.
1b). For analysis purposes, the SS was further divided
into four sub-categories, varying between 1 and 4, with
a median of 3 and an average of 2.7. The genomic
inflation factors (λ) were 1.097 for the whole cohort
and 1.072 for the covariate cohort, suggesting moder-
ate levels of population stratification in both cohorts
(Supplementary Figs. 1 and 2).
SF maps to chromosome 11
In order to map loci for fear of strangers, altogether 124
GD dogs were genotyped. The initial cohort included 52
cases and 72 controls, while the cohort with the SS as a
covariate included 44 cases and 66 controls. The PLINK
and GenABEL analyses in both cohorts revealed an
association on canine chromosome 11 (Fig. 2). When
including socialisation as a covariate, the PLINK analysis
assuming a linear model suggested a significant associa-
tion both with a Bonferroni-based threshold of sig-
nificance and when the effective number of independent
tests was considered (Fig. 2a), while the PLINK analysis
without a covariate suggested a significant signal only
with the threshold of significance calculated based on
simpleM. The GenABEL analyses yielded a signal which
did not reach genome-wide significance (Fig. 2b). This
may be a result of a known general drawback in mixed-
model approaches, causing them to lose power (by over-
correcting the structure) or possibly leading to false
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findings when candidate SNPs are included in the calcu-
lation of genomic relationship matrix (see, for example,
Würschum and Kraft45).
In three of the four association analyses, the best-
associated SNP was BICF2P368048 located at 430,548 bp
on chromosome 11. In the GenABEL analysis including a
covariate, the best-associated two SNPs spanned a region
on chromosome 11 from 12,792,149 to 12,810,167 bp
(Tables 1 and 2). Based on the best-associated SNPs in
both analyses, two regions on chromosome 11 are asso-
ciated with SF: one spanning from 0.4Mb and one around
12.8Mb (Tables 1 and 2).
Genotype plots of the best-associated regions
revealed differences between the cases and controls in
the associated regions. Although no intact haplotypes
segregating between cases and controls were seen,
there seemed to be signs of haplotype structure, with
many studied markers in linkage. In the region at
around 12.8 Mb, the two associated SNPs were in
complete linkage. To study linkage disequilibrium
within both loci, PLINK’s clumping algorithm was
used. For the locus at the beginning of chromosome 11,
two regions of linkage were identified in the analysis
without a covariate, the longer spanning from around
0.4 to 3.25 Mb (Supplementary Fig. 3a), while including
the covariate resulted in only one region, spanning
from roughly 0.4 to 2.4 Mb (Supplementary Fig. 3c).
For the locus around 12.8 Mb, two regions were
revealed in both analyses (Supplementary Fig. 3b, d).
Both associated loci include several genes and the locus
spanning from 0.4 Mb is largely syntenic to human
5q35.3 (Fig. 2e).
Table 1 Top 10 GWAS hits in association analyses
without a covariate.
PLINK (quantitative trait association analysis)
SNP name CHR Position p-Value (adjusted)
BICF2P368048 11 430,548 8.846e−07
BICF2S2294860 23 45,510,382 4.949e−06
BICF2P757289 11 404,385 2.385e−05
BICF2G630134982 37 29,628,498 1.164e−06
BICF2S2363579 21 41,417,917 3.89e−06
BICF2P1385199 6 20,120,837 4.158e−06
BICF2P1130863 11 12,729,090 8.292e−06
BICF2S23135525 11 1,177,541 8.494e−06
BICF2P54557 11 1,871,910 9.305e−06
BICF2P734487 11 1,848,161 1.047e−05
GenABEL
SNP name CHR Position p-Value
BICF2P368048 11 430,548 1.99533519991599e−06
BICF2P757289 11 404,385 6.07779244096143e−06
BICF2P54557 11 1,871,910 1.07999611246649e−05
BICF2P734487 11 1,848,161 1.17827498872651e−05
BICF2G630134982 37 29,628,498 1.19426581999159e−05
TIGRP2P144053 11 1,963,139 1.30896323580011e−05
BICF2S2294860 23 45,510,382 1.76695001064685e−05
BICF2S23135525 11 1,177,541 2.08872205163928e−05
BICF2P331249 11 861,321 2.38961915938629e−05
BICF2P1130863 11 12,729,090 2.98857919837111e−05
Table 2 Top 10 GWAS hits in association analyses with a
covariate.
PLINK (linear regression association analysis)
SNP name CHR Position p-Value (unadjusted)
BICF2P368048 11 430,548 2.058e−07
TIGRP2P147692 11 12,792,149 3.531e−07
BICF2P365517 11 12,810,167 3.531e−07
BICF2P1130863 11 12,729,090 4.251e−07
BICF2P757289 11 404,385 9.224e−07
BICF2S23135525 11 1,177,541 9.903e−07
BICF2P54557 11 1,871,910 2.561e−06
TIGRP2P144053 11 1,963,139 3.35e−06
BICF2S2294860 23 45,510,382 3.937e−06
BICF2S23445920 11 4,257,713 4.679e−06
GenABEL
SNP name CHR Position p-Value
TIGRP2P147692 11 12,792,149 3.54156004567416e−06
BICF2P365517 11 12,810,167 3.54156004567416e−06
BICF2P368048 11 430,548 3.65165246465062e−06
BICF2P1130863 11 12,729,090 5.04242375996489e−06
BICF2P757289 11 404,385 1.14950271348944e−05
BICF2P54557 11 1,871,910 1.98766237111194e−05
BICF2S23135525 11 1,177,541 2.11438133432113e−05
TIGRP2P144053 11 1,963,139 2.56387893916905e−05
BICF2S2294860 23 45,510,382 2.67885122463861e−05
BICF2S23445920 11 4,257,713 3.75198642012459e−05
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Exome and whole genome sequencing identify extensive
regions of homozygosity on chromosome 11
Eight GD case exome sequences were filtered under a
dominant model against eight GD control exome
sequences. The filtering resulted in 46 variants, of which
28 laid on chromosome 11, revealing extensive regions of
opposite homozygosity (Fig. 3 and Supplementary Table
5). Out of the 28 variants that were left on chromosome
11 after filtering, 13 were located between 0 and 3.5Mb,
while no variants were left around the two associated
SNPs around 12Mb.
To further study the variants on chromosome 11,
four case and two control GDs were whole genome
sequenced (Supplementary Table 6). After filtering
with a dominant model, 73,197 variants were left, of
which 4021 laid on chromosome 11. Extensive homo-
zygosity was seen in the GWAS associated regions.
Between 0 and 3.5 Mb, 478 variants segregating
between cases and controls were seen, including four
predicted exonic variants. Altogether 45 variants laid
between 12 and 13 Mb, including two predicted exonic
variants. Altogether 23 variants within the areas of
interest on chromosome 11 had an allele frequency of
less than 0.05, while none of these 23 variants were
predicted exonic. A total of 76 variants on chromo-
some 11 had a CS available. Four out of the 12 variants
had a CS of over 500, suggesting high conservation, and
were within the regions of interest (chr11: 430548G>A
(SNP1292511; rs9103113), chr11:1472008G>A (SNP
1292825), chr11:3390145GGGGAA>G (rs851847854)
and chr11:3416964G>T (rs851521203); Supplementary
Table 6). Additionally, chr11:1472008G>A and chr11:
3416964G>T were predicted exonic nonsynonymous
variants within interesting neuronal candidate genes
MAPK9/JNK2 and N4BP3. While variant chr11:
430548G>A was the best SNP in GWAS analyses and
was thus not followed on further, the other three
variants were studied in a larger population of GDs
included in GWAS. Furthermore, two ambiguous MEIs
and six SVs were identified within the regions of
interest (see Supplementary Table 7). One of the MEIs
flagged as being ambiguous was predicted to lie within
the exonic region of the immunity-related GTPase
family M protein 1 gene IRGM1. However, the variant
was not studied further due to the role of IRGM1 in
immune response. All other MEI and SVs were either
intergenic or intronic and were therefore not con-
sidered for further validation.
Validation of candidate variants in MAPK9, N4BP3, and
NHP2
Three candidate variants were followed up by Sanger
sequencing in a population 15 case and 25 control GDs.
Sequencing the three variants, including two predicted exo-
nic (in genes MAPK9/JNK2 and N4BP3) and one predicted
intronic variant (in the NHP2 gene), did not reveal significant
differences between cases and controls. The p-values were as
follows: 0.79 for chr11:1472008G>A (MAPK9/JNK2), 0.09 for
chr11:3390145GGGGAA>G (NHP2) and 0.95 for
chr11:3416964G>T (N4BP3). The p-value was close to sig-
nificance for chr11:3390145GGGGAA>G, but since the
variant was not seen as homozygote in any of the tested case
dogs, the difference between cases and controls did not fol-
low the pattern seen in WGS, and thus the variant was not
studied further. The results suggest that the studied three
variants are likely not causal, which is in line with the fact
that all three are previously known SNPs (although the allele
frequencies for chr11:3390145GGGGAA>G and chr11:
3416964G>T were rather low at 0.06 and 0.05; see Supple-
mentary Table 6).
Discussion
This study provides new insights into the genetics of
fearfulness in dogs. We compared GD dogs that react
Fig. 3 Whole exome variants between cases and controls on chromosome 11. Altogether 44 variants were left on chromosome 11 when
filtering eight cases against eight controls and the controls against the cases under a dominant model and allowing a maximum of either two cases
or two controls to have a deviant genotype. Light grey and dark blue colours indicate the opposite homozygote genotypes while the light blue
colour indicates a heterozygote genotype. Extensive regions of opposite homozygosity are observed in the region.
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fearfully when meeting a stranger with non-fearful GDs
and mapped a novel susceptibility locus on chromosome
11 with an extensive level of opposite homozygosity
between the case and control groups. When socialisation
was included as a covariate, the association signal
remained on chromosome 11 while other background
signals were reduced, supporting the finding. The iden-
tified gene-rich region includes potential neuronal can-
didate genes, although we failed to identify robust
candidate causative variants by exome or whole genome
sequencing.
The GWAS, exome and WGS data suggested an SF-
related locus at the beginning of chromosome 11, which is
largely syntenic with human 5q35.3. The locus is rich with
genes, although for many of them the available functional
information is limited. The most significant SNP of the
locus hits a scaffolding protein called receptor of activated
protein C kinase 1, encoded by RACK1, alternatively
named GNB2L1. RACK1 seems to have a function in
regulating neural development46, but no clear behaviour-
related function for the gene has been reported.
Another candidate gene, a mitogen-activated protein
(MAP) kinase gene, MAPK9, also known as JNK2, lies at
1.4Mb on chromosome 11. MAP kinases are divided into
three families, extracellular signal-regulated (ERK), p38,
and c-Jun N-terminal (JNK) kinases,MAPK9 belonging to
the latter family47. According to studies, JNKs are
involved in, for example, synaptic plasticity and brain
development48,49 and are thought to have a role in, for
example, Alzheimer’s and Parkinson’s diseases50. JNKs,
along with the other MAPK families have also been linked
to behaviour and anxiety. A study by Reinecke et al.48
showed some indications of changes in behaviour in an
anxiety-related testing situation in Jnk2 knock-out mice
while a study by Stefanoska et al.51 suggested that JNKs
are involved in an anxiety-modulating pathway regulated
by p38α. Additionally, Mohammad et al.52 found that
JNK1 has a role in anxiety-related behaviour. Thus,
MAPK9 provides an interesting candidate gene for fear-
fulness in GDs. No segregating coding variants were
found in MAPK9 in the whole exome analyses.
At 3.4Mb lies another candidate gene, a Fezzin family
member, NEDD4-binding protein coding gene N4BP3
that has been suggested to have a neurological function. A
study by Schmeisser et al.53 reported that N4BP3 seems to
have a role in the correct branching of neurites in
developing neurons while a knock-out study by Kiem
et al.54 indicated that the protein has a function in early
anterior neural development of vertebrates. Additionally,
loci harbouring Fezzin family members have been linked
to neurodevelopmental disorders such as autism and
schizophrenia54–56.
The GWAS data suggests also another associated area
on chromosome 11, with a two-SNP association around
12.8Mb (Fig. 2). The two SNPs are in full linkage and no
exonic variants were left in the area after filtering (Sup-
plementary Tables 5 and 6). The association may be
spurious and needs further replication. The two asso-
ciated SNPs at ~12.8Mb on chromosome 11 hit a sorting
nexin gene SNX24. Sorting nexins are a protein family
involved in endosomal sorting and signalling57, some of
which have been linked to neurological functions58.
In our previous study using the same behavioural sur-
vey, we mapped loci for noise sensitivity and general
fearfulness, which included fear of strangers and fear of
novel situations, in the German Shepherd breed14. Both
associated loci were different than the novel SF locus,
which suggests that SF in GDs has a separate genetic
background from the general fear in German Shepherds.
In addition to our study, Zapata et al.18 have also stu-
died the genetic background of stranger-oriented fear.
The study identified a different association to ours, likely
explained by their cross-breed setup with averaged phe-
notypes compared to our within-breed setup with indi-
vidual behavioural scores. Thus, both studies offer a
different view to the genetic background of human-
directed fear. In another study, Ilska et al.15 studied traits
called “Human and Object Fear” and “Non-owner-direc-
ted Aggression”, with the phenotypes only partly over-
lapping our phenotype and likely explaining different
association results.
In summary, we discovered a novel fear locus with
interesting candidate genes in dogs. Replicating the find-
ing in a larger cohort, possibly narrowing down the region
of interest and whole genome sequencing a larger set of
cases and controls to identify candidate variants in the
region will be prioritised in the future experiments. In this
study, we were unable to find a risk variant for fearfulness
in GDs, which likely reflects the complex genetic nature
and unknown genetic mechanisms underlying the phe-
notype. Fear of strangers, a form of social phobia in dogs,
may provide an important model for human anxieties for
comparative studies.
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